COMMUNIQUÉS West-GlobeNewswire

Erasca to Present at Upcoming Investor Conferences in September

29/08/2024 - 14:00

SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/ [...]

Advanced Medical Balloons appoints top-performing US life-science executive to drive business growth

29/08/2024 - 14:00

German highly innovative med-tech Advanced Medical Balloons (AMB) has named Stephen K.E. Forden as USA General Manager to expand market presence and build strategic partnerships. Lead product hygh-tec ® quickly gained [...]

Avalyn to Participate in Multiple Upcoming Investor Conferences

29/08/2024 - 14:00

CAMBRIDGE, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. , a clinical-stage biopharmaceutical company focused on development of inhaled therapies for life-threatening pulmonary diseases, today announced [...]

Vera Therapeutics to Participate at September Investor Conferences

29/08/2024 - 14:00

BRISBANE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients [...]

Crescent Innovations Inc. Reports That Inquiries Surrounding Sale of Its Bone Repair Technology Are Increasing

29/08/2024 - 14:00

WESTFORD, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Crescent Innovations Inc. reports that inquiries surrounding sale of its bone repair technology are increasing. Crescent Innovations had previously announced the sealed [...]

Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

29/08/2024 - 14:00

CAMBRIDGE, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of [...]

BetterLife Announces Fully Subscribed Private Placement Financing

29/08/2024 - 14:00

VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the development and [...]

Dentsply Sirona to Participate in Upcoming Investor Conferences

29/08/2024 - 14:00

CHARLOTTE, N.C., Aug. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences. Morgan Stanley 22 nd Annual Global [...]

89bio to Participate in Upcoming Investor Conferences

29/08/2024 - 14:00

SAN FRANCISCO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver [...]

Annexon Biosciences to Participate in Upcoming September Investor Conferences

29/08/2024 - 14:00

BRISBANE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing novel complement therapies for neuroinflammatory diseases of the body, brain and eye, today [...]

Adaptive Announces IVDR Certification for clonoSEQ® in European Union

29/08/2024 - 13:30

clonoSEQ is the first IVDR-certified test to detect minimal residual disease in patients with lymphoid malignancies SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a [...]

Zevra Therapeutics to Participate at Upcoming Investor Conferences

29/08/2024 - 13:30

CELEBRATION, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that Neil F. McFarlane, President and Chief [...]

BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer

29/08/2024 - 13:30

Dr. Bermudes is Widely Considered One of the Preeminent U.S. Clinicians in the TMS Field BURLINGTON, Mass. and JERUSALEM, Aug. 29, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “ [...]

Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson’s Disease

29/08/2024 - 13:30

Results Include Safety, Tolerability, Pharmacokinetics, and Target Engagement GT-02287, in Development for GBA1 Parkinson’s Disease, on Track to Initiate Phase 1b Trial in Patients in Q4 2024 BETHESDA, Md., Aug. 29, [...]

Inaugural Pre-JPM Partnering Week to Wrap Up 2024, Prepare for 2025

29/08/2024 - 13:30

Virtual conference Dec 2-6, 2024, prepares life science dealmakers ahead of the 2025 J.P. Morgan Health Conference SAN FRANCISCO and ZURICH, Switzerland, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Big4Bio and Biotechgate are [...]

Pyxis Oncology to Participate in Two Upcoming Investor Conferences

29/08/2024 - 13:30

BOSTON, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced that Lara [...]

BridgeBio to Present Additional Analyses from the Phase 3 ATTRibute-CM Trial of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the ESC Congress 2024 and the HFSA Annual Meeting 2024

29/08/2024 - 13:30

PALO ALTO, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, announced today that [...]

Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

29/08/2024 - 13:30

WALTHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with [...]

Notable Labs to Present Data on September 4th at SOHO 2024

29/08/2024 - 13:30

Society of Hematologic Oncology (SOHO) session to highlight volasertib program Phase 2 volasertib AML program expected to begin in the coming months FOSTER CITY, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Notable Labs, [...]